ACR Meeting Abstracts
Abstract Number: 1651 • ACR Convergence 2021
Salina Haville1, Jennifer Seifert1, Saman Barzideh1, LauraKay Moss1, Navin Rao2, Alyssa Johnsen3, Jane Buckner4, Eddie James5, Sylvia Posso4, Gary Firestein6, David Boyle7, William Robinson8, V. Michael Holers9 and Kevin Deane10, 1University of Colorado Denver, Aurora, CO, 2Janssen R&D, Spring House, PA, 3Janssen R&D, Princeton Junction, NJ, 4Benaroya Research Institute at Virginia Mason, Seattle, WA, 5Benaroya Research Institute at Virginia Mason, Monroe, WA, 6University of California San Diego, San Diego, CA, 7University of California San Diego, La Jolla, CA, 8Stanford University, Palo Alto, CA, 9University of Colorado, Denver, CO, 10University of Colorado Denver, Denver, CO
Background/Purpose: Rheumatoid arthritis (RA) has a ‘pre-RA’ period definable as elevations of antibodies to citrullinated protein antibodies (ACPA) before clinically-apparent inflammatory arthritis (IA). ACPA elevations…